Medication info

Cloavamin

Prescription medication
Ingredient · strength
L-Isoleucine›0.59g / 100mLL-Leucine›0.77g / 100mLL-Lysine Acetate›0.87g / 100mLL-Methionine›0.45g / 100mLL-Phenylalanine›0.48g / 100mLL-Threonine›0.34g / 100mLL-Tryptophan›0.13g / 100mLL-Valine›0.56g / 100mLL-Alanine›0.6g / 100mLL-Arginine›0.81g / 100mLL-Histidine›0.24g / 100mLL-Proline›0.95g / 100mLL-Serine›0.5g / 100mLGlycine›1.19g / 100mLL-Cysteine Hydrochloride›0.02g / 100mL
Manufacturer / importer
Huons Co., Ltd.
Appearance
A colorless or pale yellow transparent injection solution in a colorless, transparent glass bottle with a rubber stopper for infusion.
Packaging
250mL bottle
Approval status
Active

MFDS item code 199602121 · Notified 1996.04.02

Summary

Main use
Improvement of nutritional status (hypoproteinemia, before and after surgery, etc.) through amino acid supplementation
Who uses it
Adults · Children
Adult dosage
○ Adults: Administer by intravenous infusion up to a maximum daily dose of 1~1. 5 g of total amino acids per kg of body weight. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is desirable; as a rule, infuse at 30~40 drops per minute. Adjust the dose and infusion rate for elderly patients and patients with burns who have high protein requirements.
Children's dosage
For children, adjust the dose and infusion rate.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of nutritional status (hypoproteinemia, before and after surgery, etc.) through amino acid supplementation

  • Hypoalbuminemia
  • malnutrition
View approved original text

This product is used when there is a need for amino acid supplementation in conditions such as hypoalbuminemia, malnutrition, and pre- or post-operative situations. These conditions can arise from a deficiency of protein in the body; thus, supplementation with amino acids helps improve nutritional status, aids recovery, and supports overall body function.

Dosage and Administration

Adult dosage

○ Adults: Administer by intravenous infusion up to a maximum daily dose of 1~1. 5 g of total amino acids per kg of body weight. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is desirable; as a rule, infuse at 30~40 drops per minute. Adjust the dose and infusion rate for elderly patients and patients with burns who have high protein requirements.

Children's dosage

For children, adjust the dose and infusion rate.

Precautions

This medication must be used strictly according to the doctor's instructions. It should not be used in patients with hepatic coma symptoms or those at risk of hepatic coma. It should not be administered to patients with severe renal impairment or hypernatremia and those with metabolic nitrogen issues. This medication should not be given to patients with severe heart failure, pulmonary edema, and those with very low or no urine output. In cases where sodium or chloride ions are present, it should not be used in patients with hypernatremia, hyperchloremia, or alkalosis. Caution should be exercised when administering it to patients with severe acidosis, congestive heart failure, edema due to sodium retention, hyperkalemia, or potassium retention. Patients with liver or kidney dysfunction should also be monitored closely. This preparation contains sodium bisulfite, which may cause allergic reactions or asthma attacks in some patients, so especially asthmatic patients should be careful. Adverse reactions such as rash, nausea, vomiting, chest discomfort, palpitations, and elevated blood pressure may occur during administration, and if any unusual symptoms appear, use should be stopped immediately. Rapid administration of large amounts may lead to metabolic acidosis, so caution is needed. Serious adverse reactions such as chills, fever, headache, dyspnea, and shock may rarely occur. Patients with liver or kidney failure need regular blood tests as their blood test values may change. This medication contains electrolytes, so electrolyte balance should be monitored during large doses, and excessive doses may lead to metabolic alkalosis. Patients with a history of kidney disease, lung disease, or heart disease should avoid excessive fluid administration. Diabetic patients should regularly monitor their blood glucose levels for good glucose management. There may be interactions with other medications, so caution is especially needed when combined with tetracycline antibiotics. Safety has not been established in pregnant women, so it should be administered cautiously only when necessary. In children, the dosage should be lowered due to immature liver function, and blood ammonia levels should be frequently checked. The elderly may have decreased physical function, so the rate of administration should be slow, and dosing should be adjusted. Care should be taken regarding electrolyte content and rate of administration, and the drug should be adjusted according to body temperature. Maintain aseptic conditions during preparation and administration of the infusion solution, and do not use solutions that are discolored or cloudy. During storage, keep it sealed to protect against exposure to air or moisture, and do not use if there is leakage or discoloration.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • elevated blood pressure
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchoconstriction
  • urinary tract contraction
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma
  • anaphylactic shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is best to store it at room temperature away from direct sunlight.

Appearance and packaging

Appearance

A colorless or pale yellow transparent injection solution in a colorless, transparent glass bottle with a rubber stopper for infusion.

Package unit

250mL bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.